

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.14307786 |
| 2 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.32372210 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 4.22166727 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.22166727 |
| 5 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.13131955 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.05847754 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.05847754 |
| 8 | DNA unwinding involved in DNA replication (GO:0006268) | 3.89752990 |
| 9 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.89003710 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 3.81604276 |
| 11 | maturation of SSU-rRNA (GO:0030490) | 3.76027378 |
| 12 | heterochromatin organization (GO:0070828) | 3.72337430 |
| 13 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.70286916 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.64831507 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 3.64831507 |
| 16 | regulation of early endosome to late endosome transport (GO:2000641) | 3.63807100 |
| 17 | cotranslational protein targeting to membrane (GO:0006613) | 3.62313455 |
| 18 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.61879429 |
| 19 | protein targeting to ER (GO:0045047) | 3.60793875 |
| 20 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.59279523 |
| 21 | protein retention in ER lumen (GO:0006621) | 3.57774173 |
| 22 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.56755520 |
| 23 | mitotic chromosome condensation (GO:0007076) | 3.55410962 |
| 24 | mitochondrial fusion (GO:0008053) | 3.50936758 |
| 25 | protein localization to endoplasmic reticulum (GO:0070972) | 3.50718823 |
| 26 | viral transcription (GO:0019083) | 3.46509795 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.45912423 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.45912423 |
| 29 | pentose-phosphate shunt (GO:0006098) | 3.41901957 |
| 30 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.40128460 |
| 31 | ribosomal large subunit biogenesis (GO:0042273) | 3.39978304 |
| 32 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.38797214 |
| 33 | translational termination (GO:0006415) | 3.36365605 |
| 34 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.34566590 |
| 35 | nucleoside salvage (GO:0043174) | 3.34009380 |
| 36 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 3.30603258 |
| 37 | protein complex disassembly (GO:0043241) | 3.30066292 |
| 38 | cysteine metabolic process (GO:0006534) | 3.29906076 |
| 39 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.28932367 |
| 40 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.26784039 |
| 41 | L-serine metabolic process (GO:0006563) | 3.26457696 |
| 42 | cellular protein complex localization (GO:0034629) | 3.25984205 |
| 43 | regulation of translational fidelity (GO:0006450) | 3.25829243 |
| 44 | serine family amino acid biosynthetic process (GO:0009070) | 3.25552099 |
| 45 | protein localization to endosome (GO:0036010) | 3.25110523 |
| 46 | signal peptide processing (GO:0006465) | 3.24645999 |
| 47 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.24558885 |
| 48 | NADH metabolic process (GO:0006734) | 3.24310133 |
| 49 | UTP biosynthetic process (GO:0006228) | 3.22834401 |
| 50 | translational elongation (GO:0006414) | 3.19678561 |
| 51 | proteasome assembly (GO:0043248) | 3.19672481 |
| 52 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.15197896 |
| 53 | UV protection (GO:0009650) | 3.14081358 |
| 54 | receptor recycling (GO:0001881) | 3.13640202 |
| 55 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.09384573 |
| 56 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.07476269 |
| 57 | protein complex localization (GO:0031503) | 3.06085045 |
| 58 | galactose catabolic process (GO:0019388) | 3.03925952 |
| 59 | macromolecular complex disassembly (GO:0032984) | 3.03730942 |
| 60 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.01794132 |
| 61 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.01018132 |
| 62 | NADPH regeneration (GO:0006740) | 3.00738175 |
| 63 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.99706903 |
| 64 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.98300584 |
| 65 | aromatic amino acid family catabolic process (GO:0009074) | 2.97892402 |
| 66 | CTP metabolic process (GO:0046036) | 2.97370618 |
| 67 | CTP biosynthetic process (GO:0006241) | 2.97370618 |
| 68 | DNA strand elongation (GO:0022616) | 2.96842263 |
| 69 | sulfur amino acid catabolic process (GO:0000098) | 2.96551662 |
| 70 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.96034022 |
| 71 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.96006519 |
| 72 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.96006519 |
| 73 | L-methionine salvage (GO:0071267) | 2.95895740 |
| 74 | L-methionine biosynthetic process (GO:0071265) | 2.95895740 |
| 75 | amino acid salvage (GO:0043102) | 2.95895740 |
| 76 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.95001430 |
| 77 | respiratory chain complex IV assembly (GO:0008535) | 2.91063228 |
| 78 | protein insertion into membrane (GO:0051205) | 2.89302778 |
| 79 | pinocytosis (GO:0006907) | 2.89175178 |
| 80 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.88736195 |
| 81 | response to pheromone (GO:0019236) | 2.85350678 |
| 82 | glyoxylate metabolic process (GO:0046487) | 2.85108814 |
| 83 | UTP metabolic process (GO:0046051) | 2.84460400 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83839787 |
| 85 | ribosome biogenesis (GO:0042254) | 2.83472369 |
| 86 | metallo-sulfur cluster assembly (GO:0031163) | 2.82873548 |
| 87 | iron-sulfur cluster assembly (GO:0016226) | 2.82873548 |
| 88 | nuclear envelope reassembly (GO:0031468) | 2.82229641 |
| 89 | mitotic nuclear envelope reassembly (GO:0007084) | 2.82229641 |
| 90 | serine family amino acid metabolic process (GO:0009069) | 2.82141706 |
| 91 | ribosomal small subunit biogenesis (GO:0042274) | 2.82055756 |
| 92 | GTP biosynthetic process (GO:0006183) | 2.80836250 |
| 93 | formation of translation preinitiation complex (GO:0001731) | 2.80072888 |
| 94 | activation of MAPKKK activity (GO:0000185) | 2.79818763 |
| 95 | apoptotic process involved in morphogenesis (GO:0060561) | 2.79510875 |
| 96 | folic acid metabolic process (GO:0046655) | 2.78994306 |
| 97 | glycine metabolic process (GO:0006544) | 2.78522092 |
| 98 | pyrimidine-containing compound salvage (GO:0008655) | 2.78388009 |
| 99 | pyrimidine nucleoside salvage (GO:0043097) | 2.78388009 |
| 100 | GDP-mannose metabolic process (GO:0019673) | 2.77803919 |
| 101 | glucose catabolic process (GO:0006007) | 2.76894075 |
| 102 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.76291641 |
| 103 | mitochondrial DNA metabolic process (GO:0032042) | 2.75396842 |
| 104 | heme biosynthetic process (GO:0006783) | 2.74880706 |
| 105 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.74678068 |
| 106 | alpha-linolenic acid metabolic process (GO:0036109) | 2.74263786 |
| 107 | pentose metabolic process (GO:0019321) | 2.73505109 |
| 108 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.72380506 |
| 109 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.71110905 |
| 110 | purine-containing compound salvage (GO:0043101) | 2.71093729 |
| 111 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.70382079 |
| 112 | histone arginine methylation (GO:0034969) | 2.69552875 |
| 113 | regulation of translational termination (GO:0006449) | 2.69371274 |
| 114 | cellular metabolic compound salvage (GO:0043094) | 2.68521672 |
| 115 | translation (GO:0006412) | 2.67221541 |
| 116 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.66988697 |
| 117 | modulation by symbiont of host cellular process (GO:0044068) | 2.66760397 |
| 118 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.66221212 |
| 119 | translational initiation (GO:0006413) | 2.65440276 |
| 120 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.64976446 |
| 121 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.63622953 |
| 122 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.63593105 |
| 123 | 4-hydroxyproline metabolic process (GO:0019471) | 2.63331045 |
| 124 | viral life cycle (GO:0019058) | 2.63235827 |
| 125 | barbed-end actin filament capping (GO:0051016) | 2.63181729 |
| 126 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.62861426 |
| 127 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.62506064 |
| 128 | sulfur amino acid biosynthetic process (GO:0000097) | 2.62423323 |
| 129 | proline biosynthetic process (GO:0006561) | 2.61983521 |
| 130 | protein maturation by protein folding (GO:0022417) | 2.61686903 |
| 131 | protein targeting to mitochondrion (GO:0006626) | 2.61582059 |
| 132 | T cell apoptotic process (GO:0070231) | 2.60461893 |
| 133 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.60113323 |
| 134 | negative regulation of fibrinolysis (GO:0051918) | 2.60001424 |
| 135 | lysine catabolic process (GO:0006554) | 2.58350160 |
| 136 | lysine metabolic process (GO:0006553) | 2.58350160 |
| 137 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.57001990 |
| 138 | COPII vesicle coating (GO:0048208) | 2.56146260 |
| 139 | heme metabolic process (GO:0042168) | 2.54929518 |
| 140 | ethanol oxidation (GO:0006069) | 2.51419037 |
| 141 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.50262034 |
| 142 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.50262034 |
| 143 | protein targeting to membrane (GO:0006612) | 2.49653248 |
| 144 | serine family amino acid catabolic process (GO:0009071) | 2.48637301 |
| 145 | protein carboxylation (GO:0018214) | 2.48544269 |
| 146 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.48544269 |
| 147 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.47798205 |
| 148 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.47798205 |
| 149 | regulation of mitochondrial translation (GO:0070129) | 2.47420339 |
| 150 | proline metabolic process (GO:0006560) | 2.45625161 |
| 151 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.45041580 |
| 152 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.45041580 |
| 153 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.44482002 |
| 154 | mitochondrial calcium ion transport (GO:0006851) | 2.42868310 |
| 155 | protein autoprocessing (GO:0016540) | 2.42737675 |
| 156 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.42234580 |
| 157 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.41736407 |
| 158 | kynurenine metabolic process (GO:0070189) | 2.41655878 |
| 159 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.41610477 |
| 160 | nucleotide salvage (GO:0043173) | 2.41013505 |
| 161 | bile acid biosynthetic process (GO:0006699) | 2.40626801 |
| 162 | cellular protein complex disassembly (GO:0043624) | 2.37773443 |
| 163 | tryptophan catabolic process (GO:0006569) | 2.37599471 |
| 164 | indole-containing compound catabolic process (GO:0042436) | 2.37599471 |
| 165 | indolalkylamine catabolic process (GO:0046218) | 2.37599471 |
| 166 | NADH dehydrogenase complex assembly (GO:0010257) | 2.36036355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.83607863 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.70930288 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.92537694 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.85537567 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.76195591 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.62863274 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.61731416 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.59277901 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.56629395 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44871212 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.34143971 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.31172458 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.30191702 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.28477641 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.27459380 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.25816968 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.16577639 |
| 18 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08698337 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.07331672 |
| 20 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01316934 |
| 21 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00850224 |
| 22 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.96797430 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.92769943 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.89129818 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.88043121 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 1.80806084 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.80550429 |
| 28 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.77956526 |
| 29 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.75912276 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.75011501 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73564600 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.72884964 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72865058 |
| 34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71677227 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.71027335 |
| 36 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.70087304 |
| 37 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.69645517 |
| 38 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.68131490 |
| 39 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66602318 |
| 40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.66448625 |
| 41 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64921019 |
| 42 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64519858 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60067200 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56759796 |
| 45 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.56505638 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54920121 |
| 47 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.54732059 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.54308362 |
| 49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.52907722 |
| 50 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.52305513 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.50368776 |
| 52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.49164946 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48793194 |
| 54 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.47875590 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.47782985 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46969603 |
| 57 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.44546075 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.43762798 |
| 59 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.43446253 |
| 60 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.43405533 |
| 61 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.42769674 |
| 62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42101661 |
| 63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.41581388 |
| 64 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.40680704 |
| 65 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.40571644 |
| 66 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.39603508 |
| 67 | P68_20966046_ChIP-Seq_HELA_Human | 1.39008506 |
| 68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.38710191 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37561949 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35742414 |
| 71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35283223 |
| 72 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.34370752 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33892157 |
| 74 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.33869156 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33625933 |
| 76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33236132 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32736640 |
| 78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.32365153 |
| 79 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.30604586 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29500841 |
| 81 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28715098 |
| 82 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.28167029 |
| 83 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.27674915 |
| 84 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25232412 |
| 85 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24661853 |
| 86 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.22711659 |
| 87 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.22322058 |
| 88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22009517 |
| 89 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.21400137 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20579859 |
| 91 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19949545 |
| 92 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19233294 |
| 93 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19128444 |
| 94 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18245462 |
| 95 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18203556 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17828476 |
| 97 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17724001 |
| 98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17571705 |
| 99 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17429012 |
| 100 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16553590 |
| 101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16214183 |
| 102 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15596146 |
| 103 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.15145506 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.14639124 |
| 105 | MAF_26560356_Chip-Seq_TH1_Human | 1.14430324 |
| 106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14028005 |
| 107 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12224404 |
| 108 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12059148 |
| 109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11537984 |
| 110 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10027351 |
| 111 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08176257 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08166935 |
| 113 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08075294 |
| 114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07760501 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07240427 |
| 116 | MAF_26560356_Chip-Seq_TH2_Human | 1.07002707 |
| 117 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06938113 |
| 118 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.05811906 |
| 119 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05680777 |
| 120 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.05268516 |
| 121 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05236072 |
| 122 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04967801 |
| 123 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04720844 |
| 124 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.04701354 |
| 125 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.03995779 |
| 126 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03866884 |
| 127 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03605422 |
| 128 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03300037 |
| 129 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03236668 |
| 130 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03212060 |
| 131 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03102306 |
| 132 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.02262243 |
| 133 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02134022 |
| 134 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01897893 |
| 135 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01779569 |
| 136 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01775056 |
| 137 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01371725 |
| 138 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01350935 |
| 139 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01307762 |
| 140 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99815349 |
| 141 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98984324 |
| 142 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98093384 |
| 143 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97263470 |
| 144 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.96762989 |
| 145 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96573408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.58460645 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.42849161 |
| 3 | MP0005360_urolithiasis | 3.52854710 |
| 4 | MP0005365_abnormal_bile_salt | 3.47973300 |
| 5 | MP0009840_abnormal_foam_cell | 3.42198298 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 2.98433979 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 2.87093872 |
| 8 | MP0004233_abnormal_muscle_weight | 2.78361428 |
| 9 | MP0008260_abnormal_autophagy | 2.76082596 |
| 10 | MP0004858_abnormal_nervous_system | 2.48052245 |
| 11 | MP0004185_abnormal_adipocyte_glucose | 2.47147173 |
| 12 | MP0003123_paternal_imprinting | 2.44436403 |
| 13 | MP0003656_abnormal_erythrocyte_physiolo | 2.35226654 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.35195321 |
| 15 | MP0009379_abnormal_foot_pigmentation | 2.33233338 |
| 16 | MP0003186_abnormal_redox_activity | 2.32191673 |
| 17 | MP0005623_abnormal_meninges_morphology | 2.24318401 |
| 18 | MP0005083_abnormal_biliary_tract | 2.18201397 |
| 19 | MP0003111_abnormal_nucleus_morphology | 2.17545396 |
| 20 | MP0009278_abnormal_bone_marrow | 2.07269857 |
| 21 | MP0001849_ear_inflammation | 2.06646308 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 1.99273934 |
| 23 | MP0010329_abnormal_lipoprotein_level | 1.94367856 |
| 24 | MP0006036_abnormal_mitochondrial_physio | 1.92990097 |
| 25 | MP0005332_abnormal_amino_acid | 1.92741111 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.92602239 |
| 27 | MP0003329_amyloid_beta_deposits | 1.91300939 |
| 28 | MP0000685_abnormal_immune_system | 1.91020933 |
| 29 | MP0005084_abnormal_gallbladder_morpholo | 1.84696979 |
| 30 | MP0003195_calcinosis | 1.84459404 |
| 31 | MP0000609_abnormal_liver_physiology | 1.83745326 |
| 32 | MP0003436_decreased_susceptibility_to | 1.75755706 |
| 33 | MP0005220_abnormal_exocrine_pancreas | 1.70092902 |
| 34 | MP0000678_abnormal_parathyroid_gland | 1.69588028 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.67387898 |
| 36 | MP0005501_abnormal_skin_physiology | 1.66442656 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.66349274 |
| 38 | MP0001764_abnormal_homeostasis | 1.66097955 |
| 39 | MP0003303_peritoneal_inflammation | 1.60766646 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.56963319 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.56789159 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.56146490 |
| 43 | MP0000747_muscle_weakness | 1.53835280 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.52378917 |
| 45 | MP0002089_abnormal_postnatal_growth/wei | 1.51580318 |
| 46 | MP0009785_altered_susceptibility_to | 1.48738629 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.48578557 |
| 48 | MP0002796_impaired_skin_barrier | 1.48043002 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.47657354 |
| 50 | MP0006054_spinal_hemorrhage | 1.45049655 |
| 51 | MP0005319_abnormal_enzyme/_coenzyme | 1.44771546 |
| 52 | MP0000751_myopathy | 1.44126347 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.43904655 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.43757724 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.39604607 |
| 56 | MP0001730_embryonic_growth_arrest | 1.39508151 |
| 57 | MP0003252_abnormal_bile_duct | 1.39034108 |
| 58 | MP0009672_abnormal_birth_weight | 1.36659461 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.36056870 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.36056870 |
| 61 | MP0005671_abnormal_response_to | 1.35943549 |
| 62 | MP0008469_abnormal_protein_level | 1.34733291 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33089820 |
| 64 | MP0000750_abnormal_muscle_regeneration | 1.32495902 |
| 65 | MP0000598_abnormal_liver_morphology | 1.31938687 |
| 66 | MP0008932_abnormal_embryonic_tissue | 1.31854107 |
| 67 | MP0003011_delayed_dark_adaptation | 1.31102722 |
| 68 | MP0002118_abnormal_lipid_homeostasis | 1.30739818 |
| 69 | MP0010030_abnormal_orbit_morphology | 1.29829116 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.29396429 |
| 71 | MP0000759_abnormal_skeletal_muscle | 1.28542821 |
| 72 | MP0003566_abnormal_cell_adhesion | 1.27697329 |
| 73 | MP0002398_abnormal_bone_marrow | 1.26879788 |
| 74 | MP0005464_abnormal_platelet_physiology | 1.26096441 |
| 75 | MP0001661_extended_life_span | 1.25945332 |
| 76 | MP0005076_abnormal_cell_differentiation | 1.25833734 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 1.25780393 |
| 78 | MP0000490_abnormal_crypts_of | 1.25625741 |
| 79 | MP0008438_abnormal_cutaneous_collagen | 1.24486308 |
| 80 | MP0000689_abnormal_spleen_morphology | 1.23562840 |
| 81 | MP0000350_abnormal_cell_proliferation | 1.23137568 |
| 82 | MP0009053_abnormal_anal_canal | 1.20790824 |
| 83 | MP0005451_abnormal_body_composition | 1.20642910 |
| 84 | MP0002722_abnormal_immune_system | 1.17595937 |
| 85 | MP0002429_abnormal_blood_cell | 1.16548855 |
| 86 | MP0005375_adipose_tissue_phenotype | 1.16206023 |
| 87 | MP0000003_abnormal_adipose_tissue | 1.16137287 |
| 88 | MP0005025_abnormal_response_to | 1.15887478 |
| 89 | MP0003724_increased_susceptibility_to | 1.13918861 |
| 90 | MP0001800_abnormal_humoral_immune | 1.13339131 |
| 91 | MP0002723_abnormal_immune_serum | 1.12646572 |
| 92 | MP0005670_abnormal_white_adipose | 1.12467700 |
| 93 | MP0000358_abnormal_cell_content/ | 1.12207560 |
| 94 | MP0000716_abnormal_immune_system | 1.11594758 |
| 95 | MP0001348_abnormal_lacrimal_gland | 1.11562104 |
| 96 | MP0001853_heart_inflammation | 1.11221794 |
| 97 | MP0002933_joint_inflammation | 1.10554850 |
| 98 | MP0004957_abnormal_blastocyst_morpholog | 1.10080846 |
| 99 | MP0002420_abnormal_adaptive_immunity | 1.09545439 |
| 100 | MP0002080_prenatal_lethality | 1.08866175 |
| 101 | MP0001819_abnormal_immune_cell | 1.08236745 |
| 102 | MP0001944_abnormal_pancreas_morphology | 1.08180582 |
| 103 | MP0000465_gastrointestinal_hemorrhage | 1.06682644 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 1.05142061 |
| 105 | MP0002452_abnormal_antigen_presenting | 1.03812404 |
| 106 | MP0001845_abnormal_inflammatory_respons | 1.03239244 |
| 107 | MP0005000_abnormal_immune_tolerance | 1.03206309 |
| 108 | MP0002419_abnormal_innate_immunity | 1.02639796 |
| 109 | MP0003075_altered_response_to | 1.02190960 |
| 110 | MP0001346_abnormal_lacrimal_gland | 1.02158878 |
| 111 | MP0000313_abnormal_cell_death | 1.00876328 |
| 112 | MP0005330_cardiomyopathy | 1.00416973 |
| 113 | MP0010234_abnormal_vibrissa_follicle | 0.99057009 |
| 114 | MP0000681_abnormal_thyroid_gland | 0.98401629 |
| 115 | MP0000733_abnormal_muscle_development | 0.97711551 |
| 116 | MP0004147_increased_porphyrin_level | 0.96889288 |
| 117 | MP0006035_abnormal_mitochondrial_morpho | 0.96531277 |
| 118 | MP0001727_abnormal_embryo_implantation | 0.95067432 |
| 119 | MP0002249_abnormal_larynx_morphology | 0.94386314 |
| 120 | MP0003172_abnormal_lysosome_physiology | 0.94375433 |
| 121 | MP0001533_abnormal_skeleton_physiology | 0.93310892 |
| 122 | MP0003868_abnormal_feces_composition | 0.91235424 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.90859258 |
| 124 | MP0006082_CNS_inflammation | 0.90790217 |
| 125 | MP0009763_increased_sensitivity_to | 0.90536215 |
| 126 | MP0000858_altered_metastatic_potential | 0.89731827 |
| 127 | MP0003183_abnormal_peptide_metabolism | 0.89193203 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.88334021 |
| 129 | MP0002019_abnormal_tumor_incidence | 0.87554830 |
| 130 | MP0004087_abnormal_muscle_fiber | 0.87472326 |
| 131 | MP0002060_abnormal_skin_morphology | 0.87014399 |
| 132 | MP0001881_abnormal_mammary_gland | 0.84960159 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.84440942 |
| 134 | MP0002138_abnormal_hepatobiliary_system | 0.82567782 |
| 135 | MP0002909_abnormal_adrenal_gland | 0.81251029 |
| 136 | MP0004947_skin_inflammation | 0.80209706 |
| 137 | MP0002405_respiratory_system_inflammati | 0.80086370 |
| 138 | MP0000604_amyloidosis | 0.79867901 |
| 139 | MP0003705_abnormal_hypodermis_morpholog | 0.78225347 |
| 140 | MP0005621_abnormal_cell_physiology | 0.78084163 |
| 141 | MP0009931_abnormal_skin_appearance | 0.78064161 |
| 142 | MP0000703_abnormal_thymus_morphology | 0.77874958 |
| 143 | MP0005409_darkened_coat_color | 0.75829382 |
| 144 | MP0010630_abnormal_cardiac_muscle | 0.75634471 |
| 145 | MP0002928_abnormal_bile_duct | 0.75495442 |
| 146 | MP0003646_muscle_fatigue | 0.75474573 |
| 147 | MP0009697_abnormal_copulation | 0.75160638 |
| 148 | MP0002006_tumorigenesis | 0.75073815 |
| 149 | MP0001873_stomach_inflammation | 0.74218391 |
| 150 | MP0000343_altered_response_to | 0.73232176 |
| 151 | MP0002148_abnormal_hypersensitivity_rea | 0.73083200 |
| 152 | MP0000537_abnormal_urethra_morphology | 0.73079729 |
| 153 | MP0008007_abnormal_cellular_replicative | 0.73039059 |
| 154 | MP0005384_cellular_phenotype | 0.72827732 |
| 155 | MP0005376_homeostasis/metabolism_phenot | 0.72781213 |
| 156 | MP0003077_abnormal_cell_cycle | 0.72183651 |
| 157 | MP0003943_abnormal_hepatobiliary_system | 0.71969722 |
| 158 | MP0008874_decreased_physiological_sensi | 0.70781948 |
| 159 | MP0001542_abnormal_bone_strength | 0.67779531 |
| 160 | MP0002998_abnormal_bone_remodeling | 0.66138780 |
| 161 | MP0001697_abnormal_embryo_size | 0.65989007 |
| 162 | MP0003942_abnormal_urinary_system | 0.64783827 |
| 163 | MP0005380_embryogenesis_phenotype | 0.64462613 |
| 164 | MP0001672_abnormal_embryogenesis/_devel | 0.64462613 |
| 165 | MP0001216_abnormal_epidermal_layer | 0.64096460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.80955057 |
| 2 | Myopathic facies (HP:0002058) | 3.46264018 |
| 3 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.40211895 |
| 4 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.38308344 |
| 5 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.38308344 |
| 6 | Achilles tendon contracture (HP:0001771) | 3.33147657 |
| 7 | Hypoglycemic coma (HP:0001325) | 3.30087371 |
| 8 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22673451 |
| 9 | Ketosis (HP:0001946) | 3.18716223 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 3.17655414 |
| 11 | Reduced antithrombin III activity (HP:0001976) | 3.14890331 |
| 12 | Hepatic necrosis (HP:0002605) | 3.04867512 |
| 13 | Xanthomatosis (HP:0000991) | 3.03780177 |
| 14 | Deep venous thrombosis (HP:0002625) | 2.95670789 |
| 15 | IgM deficiency (HP:0002850) | 2.90711571 |
| 16 | Dicarboxylic aciduria (HP:0003215) | 2.89572729 |
| 17 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.89572729 |
| 18 | Abnormality of the Achilles tendon (HP:0005109) | 2.89242226 |
| 19 | Generalized aminoaciduria (HP:0002909) | 2.88180877 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 2.84355727 |
| 21 | Abnormal number of erythroid precursors (HP:0012131) | 2.83051530 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.82608665 |
| 23 | Thrombocytosis (HP:0001894) | 2.78051771 |
| 24 | Hyperacusis (HP:0010780) | 2.75977061 |
| 25 | Microvesicular hepatic steatosis (HP:0001414) | 2.75922632 |
| 26 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.75139590 |
| 27 | Abnormality of alanine metabolism (HP:0010916) | 2.75139590 |
| 28 | Hyperalaninemia (HP:0003348) | 2.75139590 |
| 29 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.74671314 |
| 30 | Intrahepatic cholestasis (HP:0001406) | 2.71691748 |
| 31 | Hyperammonemia (HP:0001987) | 2.71053946 |
| 32 | Abnormal tarsal ossification (HP:0008369) | 2.69451338 |
| 33 | Muscle stiffness (HP:0003552) | 2.63846798 |
| 34 | Microretrognathia (HP:0000308) | 2.63114406 |
| 35 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.62387327 |
| 36 | Hepatocellular necrosis (HP:0001404) | 2.60609368 |
| 37 | Trismus (HP:0000211) | 2.60066924 |
| 38 | Hyperparathyroidism (HP:0000843) | 2.56982450 |
| 39 | Distal lower limb muscle weakness (HP:0009053) | 2.55044233 |
| 40 | Hypobetalipoproteinemia (HP:0003563) | 2.54312730 |
| 41 | Progressive external ophthalmoplegia (HP:0000590) | 2.54072595 |
| 42 | Increased connective tissue (HP:0009025) | 2.53808936 |
| 43 | Exercise-induced myalgia (HP:0003738) | 2.52542844 |
| 44 | Hyperbilirubinemia (HP:0002904) | 2.50959087 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.47618262 |
| 46 | Rhabdomyolysis (HP:0003201) | 2.47547283 |
| 47 | Petechiae (HP:0000967) | 2.47167546 |
| 48 | Ketoacidosis (HP:0001993) | 2.46885451 |
| 49 | Upper motor neuron abnormality (HP:0002127) | 2.42748308 |
| 50 | Increased muscle lipid content (HP:0009058) | 2.41471049 |
| 51 | Prolonged partial thromboplastin time (HP:0003645) | 2.39980054 |
| 52 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.38017274 |
| 53 | Late onset (HP:0003584) | 2.37893000 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.36439949 |
| 55 | Increased serum ferritin (HP:0003281) | 2.36254601 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.36014934 |
| 57 | Hyperglycinemia (HP:0002154) | 2.36013428 |
| 58 | Abnormality of iron homeostasis (HP:0011031) | 2.35607120 |
| 59 | Multiple enchondromatosis (HP:0005701) | 2.35214448 |
| 60 | Generalized amyotrophy (HP:0003700) | 2.34940095 |
| 61 | Abnormality of the common coagulation pathway (HP:0010990) | 2.32414713 |
| 62 | Insomnia (HP:0100785) | 2.31617252 |
| 63 | Abnormality of the thoracic spine (HP:0100711) | 2.31083436 |
| 64 | Deep palmar crease (HP:0006191) | 2.30558759 |
| 65 | Abnormal glycosylation (HP:0012345) | 2.29507749 |
| 66 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.29507749 |
| 67 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.29507749 |
| 68 | Abnormal protein glycosylation (HP:0012346) | 2.29507749 |
| 69 | Premature rupture of membranes (HP:0001788) | 2.29421008 |
| 70 | Nonimmune hydrops fetalis (HP:0001790) | 2.29380494 |
| 71 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.25493804 |
| 72 | Long palpebral fissure (HP:0000637) | 2.25262317 |
| 73 | Polycythemia (HP:0001901) | 2.23166683 |
| 74 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.22925027 |
| 75 | Protrusio acetabuli (HP:0003179) | 2.22418282 |
| 76 | Increased serum lactate (HP:0002151) | 2.22175669 |
| 77 | Beaking of vertebral bodies (HP:0004568) | 2.20164869 |
| 78 | Cellulitis (HP:0100658) | 2.20086389 |
| 79 | Abnormality of reticulocytes (HP:0004312) | 2.20070525 |
| 80 | Increased variability in muscle fiber diameter (HP:0003557) | 2.19910881 |
| 81 | Lactic acidosis (HP:0003128) | 2.18537205 |
| 82 | Delayed CNS myelination (HP:0002188) | 2.18296810 |
| 83 | Progressive muscle weakness (HP:0003323) | 2.17486500 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 2.16782752 |
| 85 | Opisthotonus (HP:0002179) | 2.15058517 |
| 86 | Microcytic anemia (HP:0001935) | 2.14306136 |
| 87 | Type 1 muscle fiber predominance (HP:0003803) | 2.14128521 |
| 88 | Fragile skin (HP:0001030) | 2.12483293 |
| 89 | Vacuolated lymphocytes (HP:0001922) | 2.12047527 |
| 90 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.11624981 |
| 91 | Pallor (HP:0000980) | 2.07776161 |
| 92 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.07071808 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.06831683 |
| 94 | Nemaline bodies (HP:0003798) | 2.06720021 |
| 95 | Dysmetric saccades (HP:0000641) | 2.06492716 |
| 96 | Lipid accumulation in hepatocytes (HP:0006561) | 2.06411079 |
| 97 | Abnormal cartilage morphology (HP:0002763) | 2.06075990 |
| 98 | Metabolic acidosis (HP:0001942) | 2.05915839 |
| 99 | Muscle fiber inclusion bodies (HP:0100299) | 2.05407995 |
| 100 | Type I transferrin isoform profile (HP:0003642) | 2.05126206 |
| 101 | Abnormality of methionine metabolism (HP:0010901) | 2.05011369 |
| 102 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.04005122 |
| 103 | Broad distal phalanx of finger (HP:0009836) | 2.01677284 |
| 104 | Hyperthyroidism (HP:0000836) | 2.01382176 |
| 105 | Methylmalonic aciduria (HP:0012120) | 2.01085380 |
| 106 | Reticulocytopenia (HP:0001896) | 2.00088856 |
| 107 | Syringomyelia (HP:0003396) | 2.00052624 |
| 108 | Spinal cord lesions (HP:0100561) | 2.00052624 |
| 109 | Testicular atrophy (HP:0000029) | 2.00045634 |
| 110 | Chronic otitis media (HP:0000389) | 1.99893715 |
| 111 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99523039 |
| 112 | Distal upper limb amyotrophy (HP:0007149) | 1.98656508 |
| 113 | Upper limb amyotrophy (HP:0009129) | 1.98656508 |
| 114 | Reticulocytosis (HP:0001923) | 1.98432495 |
| 115 | Ragged-red muscle fibers (HP:0003200) | 1.97029718 |
| 116 | Progressive neurologic deterioration (HP:0002344) | 1.96766647 |
| 117 | Abnormality of the umbilical cord (HP:0010881) | 1.96415474 |
| 118 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95820830 |
| 119 | Abnormality of glycine metabolism (HP:0010895) | 1.95820830 |
| 120 | Bulbar palsy (HP:0001283) | 1.95571377 |
| 121 | Lethargy (HP:0001254) | 1.95478970 |
| 122 | Hypercortisolism (HP:0001578) | 1.95110553 |
| 123 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.94417470 |
| 124 | Hypertensive crisis (HP:0100735) | 1.93412020 |
| 125 | Obstructive sleep apnea (HP:0002870) | 1.93254786 |
| 126 | Macrocytic anemia (HP:0001972) | 1.92215875 |
| 127 | Brushfield spots (HP:0001088) | 1.91431398 |
| 128 | Hypolipoproteinemia (HP:0010981) | 1.90364970 |
| 129 | Nausea (HP:0002018) | 1.89310588 |
| 130 | Thoracic kyphosis (HP:0002942) | 1.89251038 |
| 131 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.88534071 |
| 132 | Vertebral compression fractures (HP:0002953) | 1.88132311 |
| 133 | Rough bone trabeculation (HP:0100670) | 1.88039841 |
| 134 | Ulnar bowing (HP:0003031) | 1.87418796 |
| 135 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.87060851 |
| 136 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.85578783 |
| 137 | Mucopolysacchariduria (HP:0008155) | 1.84409979 |
| 138 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84409979 |
| 139 | Abnormal gallbladder physiology (HP:0012438) | 1.83748518 |
| 140 | Cholecystitis (HP:0001082) | 1.83748518 |
| 141 | Abnormality of the tricuspid valve (HP:0001702) | 1.82972444 |
| 142 | Abnormal foot bone ossification (HP:0010675) | 1.82723593 |
| 143 | Aplastic anemia (HP:0001915) | 1.82165807 |
| 144 | Spinal rigidity (HP:0003306) | 1.81515467 |
| 145 | Asymmetric septal hypertrophy (HP:0001670) | 1.81006401 |
| 146 | Hypercalcemia (HP:0003072) | 1.80971905 |
| 147 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.80838486 |
| 148 | Foot dorsiflexor weakness (HP:0009027) | 1.80753054 |
| 149 | Hypoglycemic seizures (HP:0002173) | 1.80076015 |
| 150 | Mitral regurgitation (HP:0001653) | 1.80064337 |
| 151 | Exertional dyspnea (HP:0002875) | 1.80039575 |
| 152 | Fatigue (HP:0012378) | 1.79981848 |
| 153 | Thoracolumbar scoliosis (HP:0002944) | 1.78727701 |
| 154 | Joint stiffness (HP:0001387) | 1.78718278 |
| 155 | Biconcave vertebral bodies (HP:0004586) | 1.77918880 |
| 156 | Fat malabsorption (HP:0002630) | 1.77782212 |
| 157 | Back pain (HP:0003418) | 1.77708119 |
| 158 | Hyperglycinuria (HP:0003108) | 1.76554481 |
| 159 | Purpura (HP:0000979) | 1.75739995 |
| 160 | Stridor (HP:0010307) | 1.74584509 |
| 161 | Growth hormone excess (HP:0000845) | 1.71679287 |
| 162 | Myoglobinuria (HP:0002913) | 1.68828760 |
| 163 | Truncus arteriosus (HP:0001660) | 1.68095914 |
| 164 | Pseudobulbar signs (HP:0002200) | 1.67575741 |
| 165 | Calcaneovalgus deformity (HP:0001848) | 1.67404888 |
| 166 | Dysphonia (HP:0001618) | 1.66295711 |
| 167 | Abnormality of glycolipid metabolism (HP:0010969) | 1.65714863 |
| 168 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.65714863 |
| 169 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.65714863 |
| 170 | Rectal prolapse (HP:0002035) | 1.65104545 |
| 171 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.64948241 |
| 172 | Athetosis (HP:0002305) | 1.64773866 |
| 173 | EMG: myopathic abnormalities (HP:0003458) | 1.64168261 |
| 174 | Patellar dislocation (HP:0002999) | 1.62530296 |
| 175 | Gastrointestinal stroma tumor (HP:0100723) | 1.62244947 |
| 176 | Elbow flexion contracture (HP:0002987) | 1.61547511 |
| 177 | Depression (HP:0000716) | 1.60544017 |
| 178 | Visual hallucinations (HP:0002367) | 1.60523659 |
| 179 | Hand muscle atrophy (HP:0009130) | 1.60136593 |
| 180 | Overriding aorta (HP:0002623) | 1.58359039 |
| 181 | Abnormal trabecular bone morphology (HP:0100671) | 1.57931240 |
| 182 | Abnormality of the foot musculature (HP:0001436) | 1.57551551 |
| 183 | Genu recurvatum (HP:0002816) | 1.57285480 |
| 184 | Polygenic inheritance (HP:0010982) | 1.57097462 |
| 185 | Duplication of thumb phalanx (HP:0009942) | 1.56870322 |
| 186 | Single umbilical artery (HP:0001195) | 1.56850018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.50132455 |
| 2 | NME2 | 3.96767796 |
| 3 | ERN1 | 3.77477558 |
| 4 | FLT3 | 3.62475333 |
| 5 | PKN2 | 2.97127502 |
| 6 | SMG1 | 2.93115900 |
| 7 | TESK2 | 2.86593778 |
| 8 | PRPF4B | 2.86186151 |
| 9 | IRAK3 | 2.41110613 |
| 10 | TRIB3 | 2.33519652 |
| 11 | MAP4K1 | 2.31995324 |
| 12 | MAP3K10 | 2.29331783 |
| 13 | KDR | 2.21673282 |
| 14 | ICK | 2.17685966 |
| 15 | BUB1 | 2.16280005 |
| 16 | NME1 | 2.08814403 |
| 17 | STK16 | 2.03794585 |
| 18 | EIF2AK1 | 2.01670737 |
| 19 | EIF2AK3 | 1.95250851 |
| 20 | NEK1 | 1.87238340 |
| 21 | ZAP70 | 1.85808235 |
| 22 | MAP3K11 | 1.79074235 |
| 23 | TTN | 1.75954755 |
| 24 | TBK1 | 1.62186764 |
| 25 | KIT | 1.56677468 |
| 26 | BLK | 1.55068670 |
| 27 | SCYL2 | 1.49120968 |
| 28 | PIM2 | 1.47107803 |
| 29 | WEE1 | 1.45859732 |
| 30 | TESK1 | 1.45489207 |
| 31 | SIK1 | 1.41447188 |
| 32 | MAP2K3 | 1.33461465 |
| 33 | PASK | 1.31285711 |
| 34 | BTK | 1.30062301 |
| 35 | FGFR4 | 1.29166813 |
| 36 | LRRK2 | 1.27297915 |
| 37 | TLK1 | 1.26360926 |
| 38 | RPS6KA4 | 1.23752889 |
| 39 | TYK2 | 1.20742978 |
| 40 | ARAF | 1.20716067 |
| 41 | KSR2 | 1.14009460 |
| 42 | MAP3K13 | 1.12076519 |
| 43 | EEF2K | 1.11713547 |
| 44 | DYRK1B | 1.11203780 |
| 45 | MAP3K3 | 1.10995021 |
| 46 | CSF1R | 1.09284609 |
| 47 | DYRK3 | 1.08817485 |
| 48 | MAPKAPK3 | 1.05767933 |
| 49 | RIPK1 | 1.02815479 |
| 50 | VRK2 | 1.02370508 |
| 51 | CAMKK2 | 1.01587110 |
| 52 | MAP2K2 | 0.99656498 |
| 53 | TGFBR2 | 0.98933265 |
| 54 | CDK19 | 0.98150651 |
| 55 | NEK2 | 0.97331668 |
| 56 | PRKD3 | 0.96530548 |
| 57 | LIMK1 | 0.95668400 |
| 58 | MAP3K1 | 0.95629014 |
| 59 | IRAK2 | 0.94586205 |
| 60 | DMPK | 0.92517747 |
| 61 | MAP3K9 | 0.92448460 |
| 62 | TEC | 0.92399634 |
| 63 | BRAF | 0.89874931 |
| 64 | GRK6 | 0.88091877 |
| 65 | BRSK2 | 0.88012255 |
| 66 | MOS | 0.87733789 |
| 67 | MAP2K6 | 0.87680389 |
| 68 | LATS2 | 0.86883813 |
| 69 | PDPK1 | 0.86369492 |
| 70 | WNK3 | 0.85094644 |
| 71 | MAPK15 | 0.83882619 |
| 72 | EPHA2 | 0.80356708 |
| 73 | CDC7 | 0.80040423 |
| 74 | TAOK1 | 0.79640138 |
| 75 | ACVR1B | 0.78004285 |
| 76 | PAK4 | 0.77044015 |
| 77 | CDK12 | 0.76801144 |
| 78 | SYK | 0.75732677 |
| 79 | NLK | 0.72180750 |
| 80 | MAPK11 | 0.71872234 |
| 81 | CDK4 | 0.71369145 |
| 82 | MTOR | 0.71191794 |
| 83 | BMX | 0.69595655 |
| 84 | RAF1 | 0.69152992 |
| 85 | RPS6KC1 | 0.67665459 |
| 86 | RPS6KL1 | 0.67665459 |
| 87 | JAK3 | 0.65234730 |
| 88 | PTK2 | 0.64372360 |
| 89 | IKBKE | 0.62621410 |
| 90 | PTK6 | 0.62407537 |
| 91 | AURKA | 0.60858678 |
| 92 | DYRK2 | 0.59451579 |
| 93 | IRAK1 | 0.59376463 |
| 94 | MAP3K8 | 0.59023277 |
| 95 | DAPK1 | 0.58978591 |
| 96 | EPHB1 | 0.58625367 |
| 97 | PDGFRA | 0.57947307 |
| 98 | LATS1 | 0.57499213 |
| 99 | PRKG2 | 0.57018204 |
| 100 | TXK | 0.56946670 |
| 101 | VRK1 | 0.56870071 |
| 102 | TGFBR1 | 0.55900357 |
| 103 | MAPK12 | 0.55337181 |
| 104 | DAPK3 | 0.54222519 |
| 105 | TAOK3 | 0.53440635 |
| 106 | HIPK2 | 0.51087507 |
| 107 | STK10 | 0.50935846 |
| 108 | ILK | 0.50748857 |
| 109 | BRSK1 | 0.50526900 |
| 110 | PDK1 | 0.50456765 |
| 111 | MAPK4 | 0.48765998 |
| 112 | PIK3CG | 0.48711119 |
| 113 | AKT2 | 0.48620267 |
| 114 | CDK7 | 0.47674960 |
| 115 | RPS6KA2 | 0.46776654 |
| 116 | NTRK1 | 0.46120308 |
| 117 | ALK | 0.46091204 |
| 118 | LYN | 0.46059868 |
| 119 | CDK8 | 0.45677496 |
| 120 | ABL2 | 0.45398430 |
| 121 | JAK2 | 0.45374014 |
| 122 | CCNB1 | 0.44686993 |
| 123 | PBK | 0.44585502 |
| 124 | RPS6KA6 | 0.44072650 |
| 125 | PRKD2 | 0.43314245 |
| 126 | CDK11A | 0.41783421 |
| 127 | RPS6KB2 | 0.41572525 |
| 128 | CDK14 | 0.41549726 |
| 129 | IRAK4 | 0.41363670 |
| 130 | MARK2 | 0.40936275 |
| 131 | ITK | 0.40360032 |
| 132 | AURKB | 0.40287906 |
| 133 | CAMK2G | 0.39991859 |
| 134 | PIM1 | 0.39500207 |
| 135 | IKBKB | 0.38000987 |
| 136 | TAOK2 | 0.37648638 |
| 137 | CDK15 | 0.37597281 |
| 138 | PAK2 | 0.37374202 |
| 139 | STK4 | 0.36483334 |
| 140 | EPHA3 | 0.35384975 |
| 141 | RPS6KA1 | 0.34821173 |
| 142 | MST1R | 0.34672461 |
| 143 | CHEK2 | 0.34668282 |
| 144 | CHEK1 | 0.33070854 |
| 145 | TTK | 0.31932385 |
| 146 | STK24 | 0.30582941 |
| 147 | RPS6KA5 | 0.27751829 |
| 148 | CLK1 | 0.27086955 |
| 149 | MUSK | 0.26295264 |
| 150 | LCK | 0.25526439 |
| 151 | CSNK2A1 | 0.24108210 |
| 152 | PLK1 | 0.23834336 |
| 153 | MAPKAPK5 | 0.23492036 |
| 154 | PAK1 | 0.23346144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 3.11054641 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.07736198 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.95748165 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.58875126 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.46758140 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.35844104 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.27550106 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.26512784 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.22867188 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.06180282 |
| 11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.05820561 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.04695202 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.89687064 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86846217 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.86065637 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.85614702 |
| 17 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.83290147 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.81654251 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.81302926 |
| 20 | Bladder cancer_Homo sapiens_hsa05219 | 1.78399582 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.76445226 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.69176839 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.69169513 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.62265022 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59946548 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.59070200 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.57278529 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.51870611 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.51519720 |
| 30 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.49466962 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.49448584 |
| 32 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.48944223 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.44329820 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.44278364 |
| 35 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.43237512 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.42447569 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.41662246 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41464520 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.39122658 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35800800 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34366099 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32549302 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26384011 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25245367 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21964459 |
| 46 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.15827307 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14243556 |
| 48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.13120831 |
| 49 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.12043724 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.10217865 |
| 51 | Mismatch repair_Homo sapiens_hsa03430 | 1.08967477 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 1.05235462 |
| 53 | Spliceosome_Homo sapiens_hsa03040 | 1.05184655 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05081894 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04360682 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 1.03139742 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.03134386 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02172871 |
| 59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99647741 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98620516 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95794724 |
| 62 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.95680154 |
| 63 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95228140 |
| 64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93878341 |
| 65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92335765 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.92097166 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91911818 |
| 68 | Glioma_Homo sapiens_hsa05214 | 0.90271655 |
| 69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88523216 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88291110 |
| 71 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88189799 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88171319 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87696404 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87647476 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87606311 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87218629 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86200094 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85898872 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85475486 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.81873766 |
| 81 | Parkinsons disease_Homo sapiens_hsa05012 | 0.81599762 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81321871 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80244228 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.79997430 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79137253 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.78697378 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78347989 |
| 88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.78169948 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.77824282 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.76505436 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76347587 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76309144 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76243896 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75537337 |
| 95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75220065 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.75110282 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.73353756 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72829907 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72122861 |
| 100 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.71203382 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71077670 |
| 102 | Purine metabolism_Homo sapiens_hsa00230 | 0.70840169 |
| 103 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69494187 |
| 104 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69308669 |
| 105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68907472 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68814794 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67453000 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66602769 |
| 109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66149885 |
| 110 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.65137036 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.63388773 |
| 112 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.61920383 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60810124 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.59572658 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59111363 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59034657 |
| 117 | Homologous recombination_Homo sapiens_hsa03440 | 0.58042037 |
| 118 | RNA transport_Homo sapiens_hsa03013 | 0.57794691 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.56080066 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55581763 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55238695 |
| 122 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53832015 |
| 123 | Legionellosis_Homo sapiens_hsa05134 | 0.53315262 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52691272 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52495590 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.52283212 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51800383 |
| 128 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48726513 |
| 129 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48638001 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47750803 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47006249 |
| 132 | Melanoma_Homo sapiens_hsa05218 | 0.46656904 |
| 133 | Hepatitis C_Homo sapiens_hsa05160 | 0.46153161 |
| 134 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45902987 |
| 135 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45811330 |
| 136 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45018689 |
| 137 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42841713 |
| 138 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42470419 |
| 139 | Cell cycle_Homo sapiens_hsa04110 | 0.41368907 |
| 140 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40930500 |
| 141 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40823153 |
| 142 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.39828115 |
| 143 | ABC transporters_Homo sapiens_hsa02010 | 0.38931450 |
| 144 | RNA degradation_Homo sapiens_hsa03018 | 0.38572533 |
| 145 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38160789 |
| 146 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38039695 |
| 147 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35078260 |
| 148 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34847923 |
| 149 | Huntingtons disease_Homo sapiens_hsa05016 | 0.34015844 |
| 150 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33776960 |
| 151 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33593245 |
| 152 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32402180 |
| 153 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32236850 |
| 154 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30885494 |

